Cargando…
Corrigendum to “Considerations for the Treatment of Oesophageal Cancer with Radiotherapy During the COVID-19 Pandemic” [Clin Oncol 32 (2020) 354–357]
Autores principales: | Jones, C.M., Hawkins, M., Mukherjee, S., Radhakrishna, G., Crosby, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal College of Radiologists. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436418/ https://www.ncbi.nlm.nih.gov/pubmed/33795184 http://dx.doi.org/10.1016/j.clon.2021.03.010 |
Ejemplares similares
-
Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]
por: Ray, K.J., et al.
Publicado: (2016) -
Considerations for the Treatment of Oesophageal Cancer With Radiotherapy During the COVID-19 Pandemic
por: Jones, C.M., et al.
Publicado: (2020) -
Corrigendum to “Harmonization of breast cancer radiotherapy treatment planning in the Netherlands” [Tech. Innov. Patient Support Radiat. Oncol. 19 (2021) 26–32]
por: Hurkmans, Coen, et al.
Publicado: (2023) -
Corrigendum to “Review of trials currently testing treatment and prevention of COVID-19” [Clin Microbiol Infect 26.8 (2020) 988–998]
por: Fragkou, Paraskevi C., et al.
Publicado: (2021) -
Corrigendum to ‘A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetes’. [Diab. Res. Clin. Practice 166 (2020) 108294]
por: Ozder, Aclan, et al.
Publicado: (2021)